Summer 2027 Small Molecule Oncology Bioscience Intern
AstraZeneca
Summary
AstraZeneca is seeking a Small Molecule Oncology Bioscience Intern to support cancer drug discovery research at its Kendall Square/Cambridge, Massachusetts location. This lab-based internship will involve molecular and cellular biology experiments, cancer cell line maintenance, and testing drug candidates in biochemical and cell-based assays.
Job description
Responsibilities
- Design and perform molecular and cellular biology experiments, including cell culture, Western blotting, RT-PCR, and CRISPR-based gene editing.
- Maintain multiple cancer cell lines to support research activities.
- Test drug candidates using biochemical and cell-based assays.
- Collect and analyze experimental results.
- Record experimental procedures and scientific findings in a laboratory notebook.
- Summarize work and present regular updates at project team meetings.
Required Qualifications
- Currently pursuing a degree in Biology, Biochemistry, or a related field.
- Rising Junior or Rising Senior meeting the applicable graduation timeline requirements with an anticipated graduation date set for after August 2027.
- US Work Authorization is required at time of application. Applicants must have work authorization that does not require future sponsorship.
- Ability to report on site to Kendall Square/Cambridge, MA 5 days per week.
- This role will not provide relocation assistance.
- Ability to work in a lab-based role conducted in a laboratory environment.
Requirements
- Currently pursuing a degree in Biology, Biochemistry, or a related field
- Rising Junior or Rising Senior with anticipated graduation date after August 2027
- US Work Authorization required at time of application; must not require future sponsorship
- Ability to report on site to Kendall Square/Cambridge, MA 5 days per week
- No relocation assistance provided
- Ability to work in a lab-based role conducted in a laboratory environment
Benefits
- Hourly rate $37-$39
- No relocation assistance
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.